{
    "clinical_study": {
        "@rank": "5000", 
        "acronym": "CLASSIC", 
        "arm_group": [
            {
                "arm_group_label": "Liberal (target-guided) fluid resuscitation", 
                "arm_group_type": "Active Comparator", 
                "description": "Noradrenaline to MAP >= 65 mmHg.\nFluid boluses may be given as long as hemodynamic variables improve (dynamic or static variable(s) of choice). A fluid bolus is to be followed by evaluation of effect 30 minutes after the intervention at the latest.\n'Variable(s) of choice' refers to the variable(s) used to assess hemodynamic improvement.\nOnly isotonic crystalloids are to be given as resuscitation fluid; the type of isotonic crystalloid is free of choice."
            }, 
            {
                "arm_group_label": "Conservative (trigger-guided) fluid resuscitation", 
                "arm_group_type": "Experimental", 
                "description": "Noradrenaline to MAP >= 65 mmHg.\nA fluid bolus of 250-500 ml may be given followed by evaluation of effect 30 minutes after the intervention at the latest if one of the following occurs:\nPlasma lactate concentration \u2265 4 mmol/l at point-of-care testing.\nSevere hypotension (MAP < 50mmHg).\nMottling beyond edge of kneecap.\nSevere oliguria (only in the first 2 hours after randomisation).\nOnly isotonic crystalloids are to be given as resuscitation fluid; the type of isotonic crystalloid is free of choice."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this trial is to o assess feasibility of a protocol comparing conservative\n      (trigger guided) vs. liberal (target guided) approach to fluid resuscitation in patients\n      with septic shock after initial fluid resuscitation."
        }, 
        "brief_title": "Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care", 
        "condition": [
            "Septic Shock", 
            "Sepsis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Shock", 
                "Shock, Septic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Fluid resuscitation is a key intervention in treatment of sepsis, but exact indications for\n      fluid and amount of fluid administered is not established. Current guidelines for fluid\n      therapy beyond 6 hours are vague and ungraded and most observational studies suggest harm\n      with increasing positive fluid balance.\n\n      Objective To assess feasibility of a protocol comparing a conservative (trigger guided) vs.\n      liberal (target guided) approach to fluid resuscitation in patients with septic shock after\n      initial fluid resuscitation.\n\n      Design Multicentre, parallel group, centrally randomised, open label trial with adequate\n      generation of allocation sequence, and adequate allocation concealment.\n\n      Sample size 150 included patients we will be needed to show a 1.7 L difference in fluid\n      volumes between the groups based on the mean volume of resuscitation fluid given within\n      first 5 days observed in the 6S trial of 5.3 L (SD 3.7 L) with a maximal type 1 and 2 error\n      of 5% and 20% (power=80%), respectively.\n\n      Funding The trial is publicly funded by the Danish Council for Strategic Research"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult intensive care patients (age \u2265 18 years) with sepsis defined as 2 of 4 SIRS\n             criteria fulfilled within 24 hours and suspected or confirmed site of infection or\n             positive blood culture.\n\n          -  Suspected or confirmed circulatory impairment (hypotension/hypoperfusion/hypovolemia)\n             for at least 6 hours and no more than 12 hours including the hours preceding ICU\n             admission.\n\n          -  At least 30 ml/kg ideal body weight (IBW) fluid (colloids, crystalloids or blood\n             products) given in the last 6 hours.\n\n          -  Shock (defined as ongoing infusion of norepinephrine \u2265 0.10 \u00b5g/kg/min to maintain\n             blood pressure).\n\n        Exclusion Criteria:\n\n          -  Use of any form of renal replacement therapy (RRT).\n\n          -  RRT deemed imminent by the ICU doctor, i.e. RRT will be initiated within 6 hours.\n\n          -  Severe hyperkalemia (p-K > 6 mM).\n\n          -  Plasma creatinine > 350 \u00b5mol/l.\n\n          -  Life-threatening bleeding.\n\n          -  Kidney or liver transplant during current admission.\n\n          -  Burns > 10% body surface area (BSA).\n\n          -  Previously enrolled in the CLASSIC trial and has finished the 90 day observation\n             period.\n\n          -  Patients for whom it has been decided not to give full life support including\n             mechanical ventilation and RRT.\n\n          -  Consent not obtainable."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02079402", 
            "org_study_id": "RH-ITA-005", 
            "secondary_id": "2014-000902-37"
        }, 
        "intervention": {
            "arm_group_label": [
                "Liberal (target-guided) fluid resuscitation", 
                "Conservative (trigger-guided) fluid resuscitation"
            ], 
            "intervention_name": "Isotonic crystalloids", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sepsis", 
            "septic", 
            "shock", 
            "ICU", 
            "intensive", 
            "critical", 
            "resuscitation", 
            "fluid", 
            "IV", 
            "crystalloid", 
            "balance"
        ], 
        "lastchanged_date": "March 4, 2014", 
        "location": {
            "contact": {
                "email": "anders.perner@regionh.dk", 
                "last_name": "Anders Perner, MD PhD", 
                "phone": "+4535458333"
            }, 
            "contact_backup": {
                "email": "peter.buhl.hjortrup@regionh.dk", 
                "last_name": "Peter B Hjortrup, MD", 
                "phone": "+4535458456"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Copenhagen University Hospital, Rigshospitalet"
            }, 
            "investigator": {
                "last_name": "Anders Perner, MD PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care (CLASSIC) - a Randomised Clinical Trial", 
        "other_outcome": [
            {
                "measure": "All cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "90 days after randomisation"
            }, 
            {
                "measure": "All-cause mortality", 
                "safety_issue": "Yes", 
                "time_frame": "Total observation time (90 days from randomisation of last patient)"
            }, 
            {
                "measure": "Days alive without use of mechanical ventilation", 
                "safety_issue": "Yes", 
                "time_frame": "in the 90 days from randomisation"
            }, 
            {
                "measure": "Days alive without use of renal replacement therapy", 
                "safety_issue": "Yes", 
                "time_frame": "in the 90 days from randomisation"
            }, 
            {
                "measure": "Worsening of acute kidney injury according to KDIGO criteria", 
                "safety_issue": "Yes", 
                "time_frame": "Followed up until ICU discharge; an expected average of one week"
            }, 
            {
                "measure": "Ischaemic events", 
                "safety_issue": "Yes", 
                "time_frame": "Followed up until ICU discharge; an expected average of one week"
            }
        ], 
        "overall_contact": {
            "email": "anders.perner@regionh.dk", 
            "last_name": "Anders Perner, MD PhD", 
            "phone": "+4535458333"
        }, 
        "overall_contact_backup": {
            "last_name": "Peter B Hjortrup, MD", 
            "phone": "+4535458456"
        }, 
        "overall_official": {
            "affiliation": "Rigshospitalet, Denmark", 
            "last_name": "Anders Perner, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Resuscitation volume", 
            "safety_issue": "No", 
            "time_frame": "5 days after randomisation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02079402"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Scandinavian Critical Care Trials Group", 
            "investigator_full_name": "Anders Perner", 
            "investigator_title": "Chair", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Resuscitation volume", 
                "safety_issue": "No", 
                "time_frame": "Followed up until ICU discharge; an expected average of one week"
            }, 
            {
                "measure": "Fluid balance", 
                "safety_issue": "No", 
                "time_frame": "5 days after randomisation"
            }, 
            {
                "measure": "Fluid balance", 
                "safety_issue": "No", 
                "time_frame": "Followed up until ICU discharge; an expected average of one week"
            }, 
            {
                "measure": "Number of patients with protocol violations", 
                "safety_issue": "No", 
                "time_frame": "Followed up until ICU discharge; an expected average of one week"
            }, 
            {
                "measure": "Accumulated serious adverse reactions (SARs)", 
                "safety_issue": "Yes", 
                "time_frame": "Followed up until ICU discharge; an expected average of one week"
            }
        ], 
        "source": "Scandinavian Critical Care Trials Group", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Anders Perner", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}